These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16793919)

  • 1. Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations.
    Takase H; Yu CR; Ham DI; Chan CC; Chen J; Vistica BP; Wawrousek EF; Durum SK; Egwuagu CE; Gery I
    J Leukoc Biol; 2006 Sep; 80(3):538-45. PubMed ID: 16793919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
    Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance?
    Sun B; Sun SH; Chan CC; Caspi RR
    Exp Eye Res; 2000 Apr; 70(4):493-502. PubMed ID: 10865998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis.
    Ishida W; Fukuda K; Higuchi T; Kajisako M; Sakamoto S; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(1):611-7. PubMed ID: 20881307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered production of immunoregulatory cytokines by invariant Valpha19 TCR-bearing cells dependent on the duration and intensity of TCR engagement.
    Shimamura M; Huang YY; Kobayashi M; Goji H
    Int Immunol; 2009 Feb; 21(2):179-85. PubMed ID: 19106232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subretinal transfection of chitosan-loaded TLR3-siRNA for the treatment of experimental autoimmune uveitis.
    Chen S; Yan H; Sun B; Zuo A; Liang D
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):726-35. PubMed ID: 24055691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.
    Laliotou B; Dick AD
    Br J Ophthalmol; 1999 Apr; 83(4):478-85. PubMed ID: 10434874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of very late antigen-4 and leukocyte function-associated antigen-1 in experimental autoimmune uveoretinitis.
    Ishida W; Harada Y; Fukuda K; Taguchi O; Yagita H; Fukushima A
    Clin Immunol; 2014 Jul; 153(1):136-44. PubMed ID: 24787891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of cytokine and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis.
    Hashida N; Ohguro N; Nakai K; Kobashi-Hashida M; Hashimoto S; Matsushima K; Tano Y
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4224-34. PubMed ID: 16249502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.
    Sun B; Rizzo LV; Sun SH; Chan CC; Wiggert B; Wilder RL; Caspi RR
    J Immunol; 1997 Jul; 159(2):1004-11. PubMed ID: 9218623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.